The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)
Open accessAbstract
Background—: It remains uncertain whether acetylcysteine prevents contrast-induced acute kidney injury. Methods and Results—: We randomly assigned 2308 patients undergoing an intravascular angiographic procedure with at least 1 risk factor for contrast-induced acute kidney injury (age >70 years, renal failure, diabetes mellitus, heart failure, or hypotension) to acetylcysteine 1200 mg or placebo. The study drugs were administered orally twice daily for 2 doses before and 2 doses after the procedure. The allocation was concealed (central Web-based randomization). All analysis followed the intention-to-treat principle. The incidence of contrast-induced acute kidney injury (primary end point) was 12.7% in the acetylcysteine group and 12.7% in the control group (relative risk, 1.00; 95% confidence interval, 0.81 to 1.25; P =0.97). A combined end point of mortality or need for dialysis at 30 days was also similar in both groups (2.2% and 2.3%, respectively; hazard ratio, 0.97; 95% confidence interval, 0.56 to 1.69; P =0.92). Consistent effects were observed in all subgroups analyzed, including those with renal impairment. Conclusions—: In this large randomized trial, we found that acetylcysteine does not reduce the risk of contrast-induced acute kidney injury or other clinically relevant outcomes in at-risk patients undergoing coronary and peripheral vascular angiography. Clinical Trial Registration—: http://www.clinicaltrials.gov . Unique identifier: NCT00736866.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
MEHRAN, R., AYMONG, E., NIKOLSKY, E., LASIC, Z., IAKOVOU, I., FAHY, M., MINTZ, G., LANSKY, A., MOSES, J., & STONE, G. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01445-7 · Cited by 1,251
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
Early detection of acute renal failure by serum cystatin C
Herget-rosenTHAL, S., Marggraf, G., Hüsing, J., Göring, F., Pietruck, F., Janssen, O., Philipp, T., & Kribben, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00861.x · Cited by 897
N -Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De Metrio, M., Galli, S., Fabbiocchi, F., Montorsi, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054209 · Cited by 611
Dangas, G., Iakovou, I., Nikolsky, E., Aymong, E. D., Mintz, G. S., Kipshidze, N. N., Lansky, A. J., Moussa, I., Stone, G. W., Moses, J. W., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.056 · Cited by 597
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 532
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
Bartholomew, B. A., Harjai, K. J., Dukkipati, S., Boura, J. A., Yerkey, M. W., Glazier, S., Grines, C. L., & O'Neill, W. W. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.008 · Cited by 524
Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach
Tepel, M., Aspelin, P., & Lameire, N. (2006) · Circulation · doi:10.1161/circulationaha.105.595090 · Cited by 506
Gleeson, T. G., & Bulugahapitiya, S. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.183.6.01831673 · Cited by 441
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Kelly, A. M., Dwamena, B., Cronin, P., Bernstein, S. J., & Carlos, R. C. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00007 · Cited by 435
Kay, J., Chow, W. H., Chan, T. M., Lo, S. K., Kwok, O. H., Yip, A., Fan, K., Lee, C. H., & Lam, W. F. (2003) · JAMA · doi:10.1001/jama.289.5.553 · Cited by 434
Prophylaxis Strategies for Contrast-Induced Nephropathy
Pannu, N., Wiebe, N., Tonelli, M., & Alberta Kidney Disease Network, F. T. (2006) · JAMA · doi:10.1001/jama.295.23.2765 · Cited by 410
Role of Diminished Renal Function in Cardiovascular Mortality
Schrier, R. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.067 · Cited by 403
Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy
Heyman, S. N., Rosen, S., Khamaisi, M., Idée, J.-M., & Rosenberger, C. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181d2eed8 · Cited by 333
Hoffmann, U., Fischereder, M., Kru[Combining Diaeresis]ger, B., Drobnik, W., & Kra[Combining Diaeresis]mer, B. K. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106780.14856.55 · Cited by 322
Strategies to Reduce the Risk of Contrast-Induced Nephropathy
Stacul, F., Adam, A., Becker, C. R., Davidson, C., Lameire, N., McCullough, P. A., & Tumlin, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.024 · Cited by 255
Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
Briguori, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.016 · Cited by 236
Owen, R. J., Hiremath, S., Myers, A., Fraser-Hill, M., & Barrett, B. J. (2014) · Canadian Association of Radiologists Journal · doi:10.1016/j.carj.2012.11.002 · Cited by 218
Thiele, H., Hildebrand, L., Schirdewahn, C., Eitel, I., Adams, V., Fuernau, G., Erbs, S., Linke, A., Diederich, K.-W., Nowak, M., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.091 · Cited by 213
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
Nallamothu, B. K., Shojania, K. G., Saint, S., Hofer, T. P., Humes, H. D., Moscucci, M., & Bates, E. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.046 · Cited by 188
Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., Shalansky, S., Al Shamari, A., Sutander, A., Williams, T., Fox, R. S., & Levin, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.041 · Cited by 176
Gonzales, D. A., Norsworthy, K. J., Kern, S. J., Banks, S., Sieving, P. C., Star, R. A., Natanson, C., & Danner, R. L. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-32 · Cited by 160
N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trials
Zagler, A., Azadpour, M., Mercado, C., & Hennekens, C. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.055 · Cited by 145
Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary.
McCullough, P. A., Stacul, F., Becker, C. R., Adam, A., Lameire, N. H., Tumlin, J. A., & Davidson, C. J. (2006) · PubMed · Cited by 143
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
Bagshaw, S. M., McAlister, F. A., Manns, B., & Ghali, W. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.161 · Cited by 132
High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy
Trivedi, H., Daram, S., Szabó, A., Bartorelli, A. L., & Marenzi, G. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.035 · Cited by 109
N-Acetylcysteine Enhances Endothelium-Dependent Vasorelaxation in the Isolated Rat Mesenteric Artery
Lopez, B. L., Snyder, J. W., Birenbaum, D. S., & Ma, X. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70167-2 · Cited by 33
The ACT Trial Investigators (2009) · Trials · doi:10.1186/1745-6215-10-38 · Cited by 26
Implementation strategy of a severe sepsis management protocol in a tertiary hospital
de Sousa, A., Fernandes, C., Santos, G., Silva, E., Akamine, N., & Lisboa, L. (2007) · Critical Care · doi:10.1186/cc5818 · Cited by 3
Buyse, M. (1999) · doi:10.1002/(sici)1097-0258(19991230)18:24<3435::aid-sim365>3.0.co;2-o
Cited by
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Metadata
- Authors
- ACT Investigators*
- Venue
- Circulation
- Published
- 2011-09-13
- Volume
- 124
- Issue
- 11
- Pages
- 1250-1259
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1790120012
- Cited by
- 354
- References
- 40
- FWCI
- 30.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.